China Aircraft Leasing Group Holdings Limited announced that Ms. TAI Bik Yin ("Ms. TAI") has tendered her resignation as the company secretary of the Company, the Authorised Representative of the Company under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and the authorised representative of the Company for accepting service of process and notices on behalf of the Company in Hong Kong as required under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong), with effect from 1 May 2023. As the result of the resignation of Ms. TAI, Mr. LI Guohui ("Mr. LI") has been appointed as the Company Secretary, the Authorised Representative and the authorised representative of the Company for accepting service of process and notices on behalf of the Company in Hong Kong as required under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong), with effect from 1 May 2023. Mr. LI has been appointed as Chief Strategy Officer and Co-Chief Financial Officer of the Group since January 2023.

He is responsible for jointly managing the strategic planning, financing, investor relations, company secretarial matters, listing rules compliance and accounting matters of the Group. Prior to joining the Group, he has a track record in serving senior positions in the blue-chip and large-scale companies. He has served as senior manager in investment, merger and acquisition/financial analysis of International Maritime Carriers Group in Singapore and Hong Kong from 2005 to 2009 and accounting director of finance department of China Resources (Group) Co.

Ltd. from 2009 to 2013. Mr. Li has served as an executive director, the chief financial officer, the vice president and the authorised representative under Rule 3.05 of the Listing Rules of China Resources Pharmaceutical Group Limited from 2013 to 2019, a non-executive director of Dong-E E-Jiao Co. Ltd. and China Resources Double Crane Pharmaceutical Co.

Ltd.and a supervisor of Sanjiu Medical & Pharmaceutical Co. Ltd. He was an executive director and joint chief financial officer of Zhongsheng Group Holdings Limited from 2019 to 2022. Mr. Li received a Master's degree in Financial Management from Nanyang Technological University in Singapore in 2005 and a Master's degree in Business Administration from Wuhan University in 2003 and obtained professional qualifications as a Chartered Financial Analyst qualified by the CFA Institute and a Certified Public Accountant (Singapore) qualified by the Singapore Institute of Chartered Accountants.